🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a four arm, parallel study. Ten were administered a single s...
Status
Completed
Location
Clinical Trials Center, Seoul National University Hospital
Start Date
2008-09
Trial ID
NCT00969826
Treatments Being Tested
This is a single or up to 2 centers, double-blind, randomized, single-dose,...
Status
Completed
Location
WCCT Global Inc.
Start Date
2017-02-13
Trial ID
NCT03206229
Treatments Being Tested
Hypothesis : pegfilgrastim at 200 µg/kg between 12 and 18 days after previo...
Status
Unknown
Location
CHU
Start Date
TBD
Trial ID
NCT00751894
Treatments Being Tested
The study was an assessor-blind, balanced, randomized, two-treatment, two-p...
Status
Completed
Location
Lambda Therapeutic Research Ltd.
Start Date
2018-02-12
Trial ID
NCT04014062
Treatments Being Tested
This study will compare the pharmacokinetics and pharmacodynamics, after si...
Status
Completed
Location
Marcos Giusti
Start Date
2022-03-18
Trial ID
NCT04873765
Treatments Being Tested
The purpose of this study is to determine whether accelerated BEP chemother...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Centre
Start Date
2014-02
Trial ID
NCT02582697
Filgrastim (granulocyte colony-stimulating factor), which is administered b...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2000-03-03
Trial ID
NCT00004853
Treatments Being Tested
The purpose of this study is to provide data on the safety and efficacy of ...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00115414
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and tolerance of a si...
Status
Completed
Location
CHU Angers
Start Date
2008-09
Trial ID
NCT00794261
Treatments Being Tested
The purpose of this study is to describe the kinetics of lymphocyte subsets...
Status
Terminated
Location
CHU Clermont-Ferrand, Hôpital d'Estaing
Start Date
2012-02
Trial ID
NCT01541072
Treatments Being Tested